Bitcoin price today: little changed near $119k ahead of Fed meet, tariff deadline
Benjamin Richard J, the Chief Medical (TASE:BLWV) Officer of Cerus Corp (NASDAQ:CERS), recently executed a series of stock transactions according to a filing with the Securities and Exchange Commission. On March 3 and 4, Richard sold a total of 57,546 shares of Cerus Corp common stock, generating approximately $90,570. The sales were conducted at prices ranging from $1.5485 to $1.577 per share. The company, currently valued at $300 million, has shown revenue growth of 15% over the last twelve months, though InvestingPro data indicates it remains unprofitable.
These transactions were part of a pre-arranged trading plan under Rule 10b5-1, which allows insiders to sell stock at predetermined times to avoid accusations of insider trading. Following these sales, Richard holds 394,373 shares in the company. According to InvestingPro analysis, the stock shows significant price volatility, with a beta of 1.56, while maintaining strong liquidity with a current ratio of 2.39. Get access to 6 more exclusive ProTips and comprehensive analysis in the Pro Research Report, available for over 1,400 US stocks.
In other recent news, Cerus Corporation reported its fourth-quarter 2024 earnings, revealing a stronger financial performance than anticipated. The company achieved an earnings per share (EPS) of -$0.01, surpassing the forecasted -$0.02. Revenue also exceeded expectations, reaching $56.75 million compared to the projected $53.76 million. Cerus’s product revenue for the quarter grew 9% year-over-year, contributing to a 15% increase for the full year, totaling $180.3 million. Additionally, the company achieved positive adjusted EBITDA of $5.7 million for 2024. Despite these positive results, Cerus’s stock experienced a decline post-announcement. In other developments, Cerus plans to expand its international market presence, targeting regions such as EMEA, China, and Brazil. The company anticipates regulatory approval in China and aims to enter the Brazilian market later in the year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.